×
0 -0.00222717149220498 -0.00222717149220498 -0.00222717149220498 -0.00296956198960665 -0.00445434298440979 -0.00717644147488243 -0.00915614946795359
Stockreport

Regeneron Pharma Jumps On Consensus-Smashing Quarter [Investor's Business Daily]

Sanofi ADS (SNY)  More Company Research Source: Investors Business Daily
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Technology Related news 2/07/2018 Sanofi and Regeneron's Dupixent is off to a strong start in the U.S., but revenue from the eczema drug lagged... Why This Former Biotech Winner Is Now A Short-Sale Opportunity Generalists On Biotech Sidelines As Tax Reform Sweeps The U.S. Does Regeneron Pharma Have A Potential Blockbuster In 2018? U.S. Novel Drug Approvals Rocket Higher, But Overall Numbers Slide These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News Beware: Price Wars For Big Pharma, Biotech Companies On Horizon Why Biotech Stocks May Wait A While Before Feeling The Love Amgen, Regeneron Prep For Battle In 2018 Over Cholesterol Drugs Regeneron Pharmaceuticals ( REGN ) on Thursday reported adjusted income of $5.23 per share on sales of $1.58 billion for its fourth quarter, compared with $3.04 and $1.23 billion, respectively, in the year-ago period. X Analysts polled by Zacks Investment Research had called for Regeneron to [Read more]

IMPACT SNAPSHOT EVENT TIME: SNY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
SNY alerts
from News Quantified
Opt-in for
SNY alerts

from News Quantified
Opt-in for
SNY alerts

from News Quantified